|Application ||WB, IHC-P, IHC-F, IF, E|
|Calculated MW||309265 Da|
|Purification||Purified IgG prepared by affinity chromatography|
|Immunogen||Factor VIII complex|
|Shelf Life||18 months from date of despatch.|
|Other Names||von Willebrand factor, vWF, von Willebrand antigen 2, von Willebrand antigen II, VWF, F8VWF|
|Target/Specificity||Mouse anti-Human von Willebrand Factor antibody, clone 21-43 reacts with human von Willebrand's factor (also known as Factor VIII related antigen) in both plasma and tissues. Mouse anti-Human von Willebrand Factor antibody, clone 21-43 does not have anti-coagulant activity.|
|Preservative & Stabilisers||0.09% Sodium Azide|
|Storage||Store at +4℃ or at -20 ℃.|
|Precautions||Anti-Human von Willebrand Factor Antibody, clone 21-43 is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Francis, S.E. et al. (1985) Monoclonal antibodies to human FVIII: Ag and FVIIIC Pathology 17: 579-585. 3. Babich, V. et al. (2009) Differential effect of extracellular acidosis on the release and dispersal of soluble and membrane proteins secreted from the Weibel-Palade body.J Biol Chem. 284: 12459-68. 3. Francis, S. et al. (1984) Some studies with monoclonal antibodies to Human Factor VIII.Proceedings of the Haematology Society of Australia, Perth. 4. Blagoveshchenskaya, A.D. et al. (2002) Selective and signal-dependent recruitment of membrane proteins to secretory granules formed by heterologously expressed von Willebrand factor.Mol Biol Cell. 13: 1582-93. 5. Henke, P.K. et al. (2011) Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.Arterioscler Thromb Vasc Biol. 31: 43-9. 6. Knipe, L. et al. (2010) A revised model for the secretion of tPA and cytokines from cultured endothelial cellsBlood. 116: 2183-91. 7. Wakui, S. et al. (1999) Expression of vascular endothelial growth factor in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.Vet Pathol. 36: 111-6. 8. Jaschke, B. et al. (2005) Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.Cardiovasc Res. 68: 483-92. 9. Larochelle, N. et al. (2008) Downregulation of CD46 during muscle differentiation: implications for gene transfer to human skeletal muscle using group B adenoviruses.Hum Gene Ther. 19: 133-42. 10. Mirsky, R. et al. (2011) Treatment of pulmonary arterial hypertension with circulating angiogenic cells.Am J Physiol Lung Cell Mol Physiol. 301: L12-9.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.